Abstract
Rotenone and 6-hydroxydopamine are two drugs commonly used to generate Parkinson's disease animal models. They not only achieve degenerative changes of dopaminergic neurons in the substantia nigra, but also satisfy the requirements for iron deposition. However, few studies have compared the characteristics of these two models by magnetic resonance imaging. In this study, rat models of Parkinson's disease were generated by injection of 3 μg rotenone or 10 μg 6-hydroxydopamine into the right substantia nigra. At 1, 2, 4, and 6 weeks after injection, coronal whole-brain T2-weighted imaging, transverse whole-brain T2-weighted imaging, and coronal diffusion tensor weighted imaging were conducted to measure fractional anisotropy and T2* values at the injury site. The fractional anisotropy value on the right side of the substantia nigra was remarkably lower at 6 weeks than at other time points in the rotenone group. In the 6-hydroxydopamine group, the fractional anisotropy value was decreased, but T2* values were increased on the right side of the substantia nigra at 1 week. Our findings confirm that the 6-hydroxydopamine-induced model is suitable for studying dopaminergic neurons over short periods, while the rotenone-induced model m...Continue Reading
References
Dec 1, 1994·Experimental Neurology·Y IchitaniY Ibata
Jan 15, 1994·European Journal of Biochemistry·T FriedrichH Reichenbach
Dec 31, 2002·Experimental Neurology·Todd B ShererJ Timothy Greenamyre
Sep 16, 2003·Neuron·William Dauer, Serge Przedborski
Feb 10, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Nicolas LapointeFrancesca Cicchetti
Apr 2, 2004·Neurobiology of Disease·Sheng-Kwei SongDavid M Holtzman
Oct 27, 2004·Cell and Tissue Research·Andreas Schober
Mar 1, 2005·Magnetic Resonance Imaging·E Mark HaackeAndre Obenaus
Sep 24, 2005·The European Journal of Neuroscience·P M CarveyZ D Ling
Jan 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Jordi BovéSerge Przedborski
Jun 7, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·H Diana RosasDavid H Salat
Dec 21, 2006·Topics in Magnetic Resonance Imaging : TMRI·Steven D BrassRohit Bakshi
Apr 13, 2007·Neurobiology of Disease·Michael D BoskaR Lee Mosley
Nov 30, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Patrick L McGeer, Edith G McGeer
May 13, 2008·Journal of Neurology, Neurosurgery, and Psychiatry·R CaslakeC Counsell
May 12, 2012·Critical Reviews in Toxicology·Nian XiongTao Wang
Nov 16, 2012·PloS One·Dan LongMinming Zhang
Dec 29, 2012·American Journal of Alzheimer's Disease and Other Dementias·Bingmei DengJun Wang
Mar 8, 2013·PloS One·Miguel UllaFranck Durif
Jun 12, 2013·Magnetic Resonance Imaging·Ci WangShanshan Wang
Mar 8, 2014·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Eva Alonso-OrtizG Bruce Pike
Jun 5, 2015·Fiziolohichnyĭ zhurnal·L P Voitenko, A G Nikonenko
Jun 16, 2015·PloS One·Sofía Sánchez CamposGabriela Alejandra Salvador
Mar 10, 2017·International Journal of Molecular Sciences·Ramón Cacabelos